About Imagine Pharma
Imagine Pharma is a Healthcare company based in Devon (United States) founded in 2016. Polypeptide therapeutics for cardiovascular disorders and diabetes are developed. Imagine Pharma has raised $32.8 million across 2 funding rounds from investors including IP Investors. Imagine Pharma offers products and services including Oral Delivery Platform, Therapeutics Programs, and Regenerative Medicine Platform. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Drugs and Diversified. Its legal entity is IMAGINE PHARMA LLC. Its competitors include Tenaya Therapeutics, Cellino and Arrakis Therapeutics; 3 of its 3 listed competitors have raised funding.
Company details
Imagine Pharma was founded in 2016 and is based in Devon, United States. Operations focus on the biotechnology sector, where regenerative polypeptide drugs are developed for type I and II diabetes, cardiovascular disease, and pulmonary hypertension. The lead candidate, IMG-12, targets diabetes, cholesterol, and blood pressure management. All candidates remain in the preclinical phase, utilizing islet and endothelial cells in molecule development.
- Headquarters Devon, United States
- SectorsHealthcare
- Website imaginepharma.com
- Social LinkedIn
- Legal Name Imagine Pharma Llc
- Total Equity Funding$32.8M (USD)
in 2 rounds
- Latest Funding Round$32.5M (USD), Series A
Oct 2023
Products & Services of Imagine Pharma
Imagine Pharma offers a comprehensive portfolio of products and services, including Oral Delivery Platform, Therapeutics Programs, and Regenerative Medicine Platform.
Enables oral administration of biologic drugs to replace injections.
Develops novel therapies for conditions like diabetes and wounds.
Promotes production of body cell types for faster healing processes.
Funding Insights of Imagine Pharma
Imagine Pharma has successfully raised a total of $32.8M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $32.5 million completed in October 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $32.8M
- Total Rounds 2
- Last Round Series A — $32.5M
- First Round $300,000
(Jan 2023)
- Investors Count 1
All 2 funding rounds of Imagine Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2023 | $32.5M | Series A | – | – | |
| Jan 2023 | $300,000 | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in Imagine Pharma
Imagine Pharma has secured backing from 1 investor. Prominent investors backing the company include IP Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| ipinvestors.tcc.mode |
Investor details for Imagine Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Imagine Pharma
3 dated milestones of Imagine Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Imagine Pharma is founded.
- Funding First funding round of $300K.
- Funding Latest funding round, Series A, of $32.5M.
Competitors of Imagine Pharma
Imagine Pharma has 3 listed competitors in our database, 3 of them funded. They include Tenaya Therapeutics, Cellino and Arrakis Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| tenayatherapeutics.com | 2016 | San Francisco, United States | $142M | 140 | Regenerative and gene therapeutics for heart failure are developed. | |
| cellinobio.com | 2017 | Cambridge, United States | $125M | 63 | Developer of autologous cell therapies | |
| arrakistx.com | 2015 | Waltham, United States | $113M | 91 | Provider of tools for the analysis of RNA structures |
Detailed competitors of Imagine Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Imagine Pharma
Websites that share an audience with Imagine Pharma (imaginepharma.com).
Websites whose visitors overlap most with Imagine Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| plexision.com | 100% | 3.2K | #5,846,553 | View details | |
| novasenta.com | 100% | 2.4K | #6,002,810 | View details | |
| starrlifesciences.com | 100% | 2.8K | #5,697,666 | View details | |
| ecmtherapeutics.com | 98% | 2.6K | #6,640,901 | View details | |
| bluespherebio.com | 98% | 2.5K | #6,529,430 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Imagine Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
3 companies that operate in the same segment as Imagine Pharma (Cardiac and Vascular Disorders) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | 255 | ||
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Imagine Pharma
Complete news archive for Imagine Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Imagine Pharma
Imagine Pharma was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Imagine Pharma is headquartered in Devon, United States. It is registered at Devon, Pennsylvania, United States.
Imagine Pharma is a funded company, having raised a total of $32.8M across 2 funding rounds to date. The company's 1st funding round was a Seed of $300K, raised on Jan 2023.
Imagine Pharma was founded in 2016 and is based in Devon, United States. Operations focus on the biotechnology sector, where regenerative polypeptide drugs are developed for type I and II diabetes, cardiovascular disease, and pulmonary hypertension. The lead candidate, IMG-12, targets diabetes, cholesterol, and blood pressure management. All candidates remain in the preclinical phase, utilizing islet and endothelial cells in molecule development.
Imagine Pharma's top competitors include Tenaya Therapeutics, Cellino and Arrakis Therapeutics.
Imagine Pharma offers Oral Delivery Platform, Therapeutics Programs, and Regenerative Medicine Platform.
Imagine Pharma has 1 investor. Key investors include IP Investors.
Imagine Pharma operates through Imagine Pharma Llc.